Lionel Ades, MD, PhD

Universite Paris-Diderot, Assistance Publique Hopitaux de Paris, Hopital Saint-Louis
INSERM UMR-S1131, Institut Univeristaire d'Hematologie
1 Ave Claude Vellefaux
Paris France 75010
467 A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial
797 Clinical and Molecular Characteristics of DDX41-Mutated Patients in a Large Cohort of Sporadic MDS/AML
1298 Aplastic Anemia in the Elderly: A Nationwide Survey on Behalf of the French Reference Center for Aplastic Anemia
4045 Anti-CD123 Targeted Therapy with Talacotuzumab in Advanced MDS and AML after Failing Hypomethylating Agents - Final Results of the Samba Trial